BioCentury
ARTICLE | Financial News

CanSino raises $30M in third round

November 4, 2015 2:15 AM UTC

Tianjin CanSino Biotechnology Inc. (Tianjin, China) said it raised about $30 million in its third round of venture funding. Qiming Venture Partners led the round, while Lilly Asia Ventures and other existing investors also participated.

This month, CanSino expects to begin construction of a vaccine manufacturing facility capable of producing more than 10 human vaccine products. CanSino's pipeline includes vaccines against tuberculosis and pneumococcal infections. ...